Fibromyalgia and Xyrem
Links shared publicly online about this topic
Hospital Pharmacy Europe - EMA turns down Xyrem for adult fibromyalgia syndrome
hospitalpharmacyeurope.com — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at hospitalpharmacyeurope.com
Most Recently Shared on March 18, 2011 at 10:56 pm By:
EMA turns down Xyrem for adult fibromyalgia syndrome: The European Medicines Agency will not recommend Xyrem as ... http://bit.ly/hTzpGX
FDA Rejects Xyrem As Fibromyalgia Treatment - Health News - redOrbit
redorbit.com — “A Food and Drug Administration (FDA) advisory panel on Friday significantly rejected the application of Jazz Pharmaceuticals for the approval of Xyrem (sodium oxybate) for the treatment of fibromyalgia.” View full resource at redorbit.com
Most Recently Shared on August 22, 2010 at 5:09 pm By:
FDA Rejects Xyrem As Fibromyalgia Treatment: A Food and Drug Administration (FDA) advisory panel on Friday signifi... http://bit.ly/b0K01V
Hospital Pharmacy Europe - EMA turns down Xyrem for adult fibromyalgia syndrome
hospitalpharmacyeurope.com — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at hospitalpharmacyeurope.com
Most Recently Shared on March 20, 2011 at 6:58 am By:
EMA turns down Xyrem for adult fibromyalgia syndrome http://bit.ly/i2k8Ze
FDA says no to Jazz Pharma fibromyalgia drug
health.yahoo.net — “In a story Oct. 11, The Associated Press reported that the Food and Drug Administration denied approval to JZP-6, a Jazz Pharmaceuticals drug candidate intended to treat fibromyalgia. The drug is approved under the name Xyrem as a treatment for narcolepsy and cataplexy.” View full resource at health.yahoo.net
Most Recently Shared on October 13, 2010 at 12:37 am By:
Jane Anderson Healthy Eating Advisor
FDA says no to Jazz Pharma fibromyalgia drug http://bit.ly/cd6LDi
FDA says no to Jazz Pharma fibromyalgia drug
health.yahoo.net — “In a story Oct. 11, The Associated Press reported that the Food and Drug Administration denied approval to JZP-6, a Jazz Pharmaceuticals drug candidate intended to treat fibromyalgia. The drug is approved under the name Xyrem as a treatment for narcolepsy and cataplexy.” View full resource at health.yahoo.net
Most Recently Shared on October 13, 2010 at 12:35 am By:
Jennifer Ann Grisso Nurse and Active Health Library
FDA says no to Jazz Pharma fibromyalgia drug: In a story Oct. 11, The Associated Press reported that the Food and ... http://bit.ly/aorzqa
Medical News: FDA Panel Looks at CNS Depressant for Fibromyalgia - in Rheumatology, Fibromyalgia from MedPage Today
medpagetoday.com — “BETHESDA, Md. -- A joint FDA advisory committee will meet here Friday to consider whether the narcolepsy drug sodium oxybate (Xyrem) should receive an additional indication to treat fibromyalgia.” View full resource at medpagetoday.com
Most Recently Shared on August 19, 2010 at 10:58 pm By:
Patricia Grace Eldercare Expert
FDA Panel Looks at CNS Depressant for Fibromyalgia: BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committe... http://bit.ly/cuYj9k
FDA Panel Looks at CNS Depressant for Fibromyalgia - QualityPoint Technologies
qualitypointtech.net — “BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committee will meet here Friday to consider whether the narcolepsy drug sodium oxybate (Xyrem) should receive an additional indication to treat fibromyalgia.” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 11:21 pm By:
FDA Panel Looks at CNS Depressant for Fibromyalgia: BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committe... http://bit.ly/9l81Vz
FDA Panel Roundly Rejects CNS Drug for Fibromyalgia - QualityPoint Technologies
qualitypointtech.net — “BETHESDA, Md. (MedPage Today) -- A federal advisory panel has voted 20-2 to recommend that the FDA not grant approval for an expanded indication for sodium oxybate (Xyrem) -- also known as GHB -- to treat fibromyalgia.” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 11:57 pm By:
FDA Panel Roundly Rejects CNS Drug for Fibromyalgia: BETHESDA, Md. (MedPage Today) -- A federal advisory panel has... http://bit.ly/beJXWE
Forbes Readers On Jazz And Dendreon - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “I was grateful and touched by the comments readers shared on my story about an expert panel's rejection of Jazz Pharmaceuticals' Xyrem for fibromyalgia and my defense of that drug's continued use as a treatment for narcolepsy. Erica1234 worried that the rejection could make it uneconomical for Jazz to keep [...]” View full resource at blogs.forbes.com
Most Recently Shared on September 8, 2010 at 7:15 pm By:
Forbes Readers On Jazz And Dendreon: Touching stories about the narcolepsy drug Xyrem; controversy on Dendreon and... http://bit.ly/dDeQa1
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Fibromyalgia OW
Organizing fibromyalgia resources shared by health experts, advocates, and organizations into WisdomCards.
-
Fibromyalgia OW
Organizing fibromyalgia resources shared by health experts, advocates, and organizations into WisdomCards.
-
Gina Selir
I am the author of the Fibromyalgia Natural Program and I am available to answer any question you may have about fibro.
Advertisement
